全文获取类型
收费全文 | 1463912篇 |
免费 | 103058篇 |
国内免费 | 5279篇 |
专业分类
耳鼻咽喉 | 20086篇 |
儿科学 | 46229篇 |
妇产科学 | 40836篇 |
基础医学 | 210534篇 |
口腔科学 | 42433篇 |
临床医学 | 126741篇 |
内科学 | 285583篇 |
皮肤病学 | 34248篇 |
神经病学 | 115881篇 |
特种医学 | 58056篇 |
外国民族医学 | 399篇 |
外科学 | 224781篇 |
综合类 | 33256篇 |
现状与发展 | 1篇 |
一般理论 | 473篇 |
预防医学 | 99263篇 |
眼科学 | 34741篇 |
药学 | 109221篇 |
4篇 | |
中国医学 | 4310篇 |
肿瘤学 | 85173篇 |
出版年
2018年 | 16615篇 |
2017年 | 12892篇 |
2016年 | 14867篇 |
2015年 | 16809篇 |
2014年 | 22238篇 |
2013年 | 32499篇 |
2012年 | 44167篇 |
2011年 | 45632篇 |
2010年 | 27423篇 |
2009年 | 25320篇 |
2008年 | 43146篇 |
2007年 | 46190篇 |
2006年 | 46567篇 |
2005年 | 44970篇 |
2004年 | 43397篇 |
2003年 | 42054篇 |
2002年 | 40576篇 |
2001年 | 75930篇 |
2000年 | 77736篇 |
1999年 | 64882篇 |
1998年 | 16964篇 |
1997年 | 14760篇 |
1996年 | 14241篇 |
1995年 | 13413篇 |
1994年 | 12384篇 |
1993年 | 11417篇 |
1992年 | 48397篇 |
1991年 | 46616篇 |
1990年 | 45540篇 |
1989年 | 44248篇 |
1988年 | 40062篇 |
1987年 | 39724篇 |
1986年 | 36851篇 |
1985年 | 35325篇 |
1984年 | 25702篇 |
1983年 | 21376篇 |
1982年 | 12243篇 |
1981年 | 10837篇 |
1979年 | 23023篇 |
1978年 | 16095篇 |
1977年 | 13721篇 |
1976年 | 12379篇 |
1975年 | 13478篇 |
1974年 | 16036篇 |
1973年 | 15331篇 |
1972年 | 14359篇 |
1971年 | 13536篇 |
1970年 | 12501篇 |
1969年 | 11831篇 |
1968年 | 10916篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
92.
Changhyun Kim B.S. Brittany G. Craiglow M.D. Kalman L. Watsky M.D. Richard J. Antaya M.D. 《Pediatric dermatology》2015,32(4):e161-e162
A 17‐year‐old boy presented with recurring severe dermatitis of the face of 5‐months duration that resembled impetigo. He had been treated with several courses of antibiotics without improvement. Biopsy showed changes consistent with allergic contact dermatitis and patch testing later revealed sensitization to benzoyl peroxide, which the patient had been using for the treatment of acne vulgaris. 相似文献
93.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene 下载免费PDF全文
94.
Mónica Berger-González Ana Vides-Porras Sarah Strauss Michael Heinrich Simeón Taquirá Pius Krütli 《Medical anthropology》2016,35(4):353-367
Biomedicine fosters particular styles of interaction and behaviors, with the therapeutic relationship seen as occurring between a doctor and patient. In contrast, where alternative modalities of healing are practiced, relationships go beyond a dyadic interaction and include wider social networks. In this article, we propose the existence of a ‘therapeutic unit’ in Maya healing practices in Guatemala that binds healer, wellness seeker, family, and community members, along with the spiritual and natural realms, into a coherent system requiring all of these elements to achieve success. Drawing on interviews with 67 Maya healers, we describe healers’ understanding of raxnaq’il nuk’aslemal (well-being), and show how these interactions activate wider networks that play crucial roles during treatments. We highlight how holism is expressed in relationships typical of indigenous healing systems, and how an appreciation of this is important for developing culturally appropriate health care provision systems. 相似文献
95.
Assessment of Myocardial Infarct Size by Three‐Dimensional and Two‐Dimensional Speckle Tracking Echocardiography: A Comparative Study to Single Photon Emission Computed Tomography 下载免费PDF全文
96.
97.
98.
99.
Piel S. M. Burger T. Wünsch A. Farin-Glattacker E. 《Monatsschrift für Kinderheilkunde》2020,168(9):819-825
Monatsschrift Kinderheilkunde - Bedürfnisse onkologisch erkrankter Kinder im Kontext der Versorgung sind noch wenig erforscht, was u.?a. in einem Mangel an entsprechenden... 相似文献
100.
The Venom of Philippine Tarantula (Theraphosidae) Contains Peptides with Pro-Oxidative and Nitrosative-Dependent Cytotoxic Activities against Breast Cancer Cells (MCF-7) In Vitro 下载免费PDF全文
Simon Miguel M LopezJeremey S AguilarJerene Bashia B FernandezAngelic Gayle J LaoMitzi Rain R EstrellaMark Kevin P Devanadera Anna Beatriz R Mayor Leonardo A Guevarra Jr Myla R Santiago-Bautista Olga M NunezaLibrado Santiago 《Asian Pacific journal of cancer prevention》2020,21(8):2423-2430
Background: Breast cancer is a multifactorial disease that affects women worldwide. Its progression is likely to be executed by oxidative stress wherein elevated levels of reactive oxygen and nitrogen species drive several breast cancer pathologies. Spider venom contains various pharmacological peptides which exhibit selective activity to abnormal expression of ion channels on cancer cell surface which can confer potent anti-cancer activities against this disease. Methods: Venom was extracted from a Philippine tarantula by electrostimulation and fractionated by reverse phase-high performance liquid chromatography (RP-HPLC). Venom fractions were collected and used for in vitro analyses such as cellular toxicity, morphological assessment, and oxidative stress levels. Results: The fractionation of crude spider venom generated several peaks which were predominantly detected spectrophotometrically and colorimetrically as peptides. Treatment of MCF-7 cell line of selected spider venom peptides induced production of several endogenous radicals such as hydroxyl radicals (•OH), nitric oxide radicals (•NO), superoxide anion radicals (•O2−) and lipid peroxides via malondialdehyde (MDA) reaction, which is comparable with the scavenging effects afforded by 400 µg/mL vitamin E and L-cysteine (p<0.05). Concomitantly, the free radicals produced decrease the mitochondrial membrane potential and metabolic activity as detected by rhodamine 123 and tetrazolium dye respectively (p>0.05). This is manifested by cytotoxicity in MCF-7 cells as seen by increase in membrane blebbing, cellular detachment, caspase activity and nuclear fragmentation. Conclusion: These data suggest that the Philippine tarantula venom contains peptide constituents exhibiting pro-oxidative and nitrosative-dependent cytotoxic activities against MCF-7 cells and can indicate mechanistic insights to further explore its potential application as prooxidants in cancer therapy. 相似文献